Acorda Therapeutics Inc ROCE
Cos'è ROCE di Acorda Therapeutics Inc?
ROCE di Acorda Therapeutics Inc è 221.80%
Qual è la definizione di ROCE?
Il ritorno sul capitale investito (ROCE) è un rapporto finanziario che misura la redditività di un'azienda e l'efficienza con cui viene utilizzato il suo capitale.
Return on capital employed (ROCE) is the total amount of capital that a company has utilized in order to generate profits. It is the sum of shareholders' equity and debt liabilities. It can be simplified as total assets minus current liabilities.
ROCE is especially useful when comparing the performance of companies in capital-intensive sectors. ROCE considers debt and other liabilities as well compared to other fundamentals which only analyze profitability related to a company’s common equity. This provides a better indication of financial performance for companies with significant debt. For a company, the ROCE trend over the years is also an important indicator of performance. In general, investors tend to favor companies with stable and rising ROCE numbers over companies where ROCE is volatile and bounces around from one year to the next.
Instead of using capital employed at an arbitrary point in time, analysts and investors often calculate ROCE based on the average capital employed (ROACE), which takes the average of opening and closing capital employed for the time period.
ROCE di aziende nel Health Care settore su NASDAQ rispetto a Acorda Therapeutics Inc
Cosa fa Acorda Therapeutics Inc?
acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate
Aziende con roce simili a Acorda Therapeutics Inc
- Cyon Exploration ha ROCE di 204.94%
- Champion Gaming Inc ha ROCE di 205.91%
- Cannabis Strategic Ventures ha ROCE di 208.68%
- NorZinc ha ROCE di 212.68%
- Echo Plc ha ROCE di 215.96%
- RattanIndia Power ha ROCE di 218.16%
- Acorda Therapeutics Inc ha ROCE di 221.80%
- Dxi Capital Corp ha ROCE di 223.25%
- Opgen Inc ha ROCE di 223.61%
- Rose Hill Acquisition Corp ha ROCE di 224.74%
- The Alkaline Water ha ROCE di 225.00%
- Freedom Oil And Gas Ltd ha ROCE di 225.06%
- Nicolas Miguet et Associes SA ha ROCE di 227.31%